Bank of Nova Scotia »

United Therapeutics Corporation shares owned by Bank of Nova Scotia

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Bank of Nova Scotia from 13F filings

Historical chart of Bank of Nova Scotia investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Bank of Nova Scotia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Bank of Nova Scotia

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 3.1k 358.35
2024-03-31 $17M 72k 229.72
2023-12-31 $5.5M 25k 219.88
2023-09-30 $691k 3.1k 225.87
2023-06-30 $907k 4.1k 220.75
2023-03-31 $971k 4.3k 223.95
2022-03-31 $21M 115k 179.41
2021-12-31 $1.1M 4.9k 216.10
2021-06-30 $510k 2.8k 179.26
2021-03-31 $493k 2.9k 167.40
2020-12-31 $607k 4.0k 151.79
2020-09-30 $532k 5.3k 100.99
2020-06-30 $495k 4.1k 121.00
2019-06-30 $2.5M 32k 78.06
2019-03-31 $2.5M 21k 117.38

More positions owned by Bank of Nova Scotia

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Cibc Cad (CM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Bank Of Montreal Cadcom (BMO)
Enbridge (ENB)
Amazon (AMZN)
Tc Energy Corp (TRP)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Bank of Nova Scotia

Top funds holding United Therapeutics Corporation

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Geode Capital Management
LSV Asset Management
AQR Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Hanna Zanoni
Pacer Advisors
Alliancebernstein
Nuveen Asset Management

View all funds holding United Therapeutics Corporation